{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:41:05Z","timestamp":1792446065808,"version":"4.5.0"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["XKPF2024A5002"],"award-info":[{"award-number":["XKPF2024A5002"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["24XHCR04A"],"award-info":[{"award-number":["24XHCR04A"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20224Y0108"],"award-info":[{"award-number":["20224Y0108"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2510900"],"award-info":[{"award-number":["2024YFC2510900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.preteyeres.2026.101531","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:02:25Z","timestamp":1790175745000},"page":"101531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Retinopathy of prematurity in the anti-VEGF era: Screening systems and practical treatment decision-making across anti-VEGF, laser, and surgery"],"prefix":"10.1016","volume":"115","author":[{"given":"Xuerui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zupeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haodong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.preteyeres.2026.101531_bib1","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1073\/pnas.1801379115","article-title":"VEGF-B is a potent antioxidant","volume":"115","author":"Arjunan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.preteyeres.2026.101531_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bjo.38.7.385","article-title":"Pathological basis of retrolental fibroplasia","volume":"38","author":"Ashton","year":"1954","journal-title":"Br. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.preteyeres.2026.101531_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.35879","article-title":"The use of postnatal weight gain algorithms to predict severe or type 1 retinopathy of prematurity: a systematic review and meta-analysis","volume":"4","author":"Athikarisamy","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.preteyeres.2026.101531_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/APO.0000000000000313","article-title":"Retinopathy of prematurity: how to prevent the third epidemics in developing countries","volume":"9","author":"Azad","year":"2020","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.preteyeres.2026.101531_bib6","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s40123-025-01157-4","article-title":"Systemic effects of intravitreal Anti-VEGF therapy: a review of safety across organ systems","volume":"14","author":"Banerjee","year":"2025","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.preteyeres.2026.101531_bib7","first-page":"243","article-title":"Hypertension and ischemic stroke after aflibercept for retinopathy of prematurity","volume":"13","author":"Bazvand","year":"2020","journal-title":"Int. Med. Case Rep. J."},{"key":"10.1016\/j.preteyeres.2026.101531_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamaophthalmol.2019.4517","article-title":"Validation of the postnatal growth and retinopathy of prematurity screening criteria","volume":"138","author":"Binenbaum","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib9","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamaophthalmol.2018.2753","article-title":"Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study","volume":"136","author":"Binenbaum","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.preteyeres.2026.101531_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/tmj.2020.0010","article-title":"Telemedicine for retinopathy of prematurity","volume":"26","author":"Brady","year":"2020","journal-title":"Telemed. J. E-Health: Off. J. Am. Telemed. Assoc."},{"key":"10.1016\/j.preteyeres.2026.101531_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/jamaophthalmol.2018.1934","article-title":"Automated diagnosis of plus disease in retinopathy of prematurity using deep convolutional neural networks","volume":"136","author":"Brown","year":"2018","journal-title":"JAMA Ophthalmol."},{"issue":"19","key":"10.1016\/j.preteyeres.2026.101531_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99448","article-title":"Thrombocytopenia is associated with severe retinopathy of prematurity","volume":"3","author":"Cakir","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.preteyeres.2026.101531_bib14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ophtha.2020.10.025","article-title":"Evaluation of a deep learning\u2013derived quantitative retinopathy of prematurity severity scale","volume":"128","author":"Campbell","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bjophthalmol-2012-302276","article-title":"Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity","volume":"97","author":"Castellanos","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/bjo-2023-323723","article-title":"Long-term surgical outcomes and prognostic factors for advanced-stage retinopathy of prematurity after vitrectomy","volume":"109","author":"Chang","year":"2024","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/bjo-2023-323723","article-title":"Long-term surgical outcomes and prognostic factors for advanced-stage retinopathy of prematurity after vitrectomy","volume":"109","author":"Chang","year":"2025","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajo.2018.09.039","article-title":"A spectrum of regression following intravitreal bevacizumab in retinopathy of prematurity","volume":"198","author":"Chen","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3928\/23258160-20211124-01","article-title":"Aflibercept for retinopathy of prematurity: a systematic review and meta-analysis","volume":"52","author":"Chen","year":"2021","journal-title":"Ophthalm. Surg. Lasers Imag. Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.961379","article-title":"An iris puncture technique for restoration of the anterior chamber in vitrectomy for pediatric vitreoretinopathies","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.preteyeres.2026.101531_bib21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/bjophthalmol-2021-319131","article-title":"Systemic conbercept pharmacokinetics and VEGF pharmacodynamics following intravitreal injections of conbercept in patients with retinopathy of prematurity","volume":"106","author":"Cheng","year":"2022","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ophtha.2024.01.006","article-title":"Conbercept versus laser for the treatment of infants with zone II retinopathy of prematurity","volume":"131","author":"Cheng","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.oret.2026.01.020","article-title":"Global validation of the postnatal growth and retinopathy of prematurity screening model: a systematic review and meta-analysis","volume":"10","author":"Chi","year":"2026","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archopht.125.7.875","article-title":"Interexpert agreement of plus disease diagnosis in retinopathy of prematurity","volume":"125","author":"Chiang","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib25","first-page":"933","article-title":"Screening guidelines for retinopathy of prematurity in China (2014)","volume":"50","year":"2014","journal-title":"Chin. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11912-013-0368-7","article-title":"Aflibercept--a decoy VEGF receptor","volume":"16","author":"Ciombor","year":"2014","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.preteyeres.2026.101531_bib27","article-title":"Cataract surgery in children with retinopathy of prematurity (ROP): surgical outcomes","volume":"101","author":"Cn","year":"2017","journal-title":"Br. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.preteyeres.2026.101531_bib28","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.molmed.2018.05.002","article-title":"Building blood vessels with vascular progenitor cells","volume":"24","author":"Colunga","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.preteyeres.2026.101531_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cotox.2017.11.008","article-title":"Oxidative stress in the retina: implications for Retinopathy of Prematurity","volume":"7","author":"Couroucli","year":"2018","journal-title":"Curr. Opin Toxicol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jamaophthalmol.2024.0045","article-title":"Multinational external validation of autonomous retinopathy of prematurity screening","volume":"142","author":"Coyner","year":"2024","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"106","year":"1988","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2023.101230","article-title":"Neonatal sepsis as a cause of retinopathy of prematurity: an etiological explanation","volume":"98","author":"Dammann","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"issue":"16","key":"10.1016\/j.preteyeres.2026.101531_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells13161371","article-title":"Novel small molecules with anti-inflammatory and anti-angiogenic activity in a mouse model of oxygen-induced retinopathy","volume":"13","author":"Dayoub","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.preteyeres.2026.101531_bib34","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/IAE.0b013e3181610f97","article-title":"Three-year anatomic and visual outcomes after vitrectomy for stage 4B retinopathy of prematurity","volume":"28","author":"El Rayes","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib36","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.ophtha.2019.03.048","article-title":"Neurodevelopmental outcomes after intravitreal bevacizumab therapy for retinopathy of prematurity: a prospective case-control study","volume":"126","author":"Fan","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib37","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.18240\/ijo.2022.09.05","article-title":"Staged lensectomy and vitrectomy in the management of stage 5C retinopathy of prematurity with corneal opacification: long-term follow up","volume":"15","author":"Fei","year":"2022","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib38","doi-asserted-by":"crossref","first-page":"F179","DOI":"10.1136\/archdischild-2014-306207","article-title":"Impact of retinopathy of prematurity on ocular structures and visual functions","volume":"100","author":"Fielder","year":"2015","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.preteyeres.2026.101531_bib39","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2026.101531_bib40","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1111\/aos.17515","article-title":"Visual acuity, amblyopia and refractive error in preterm children with and without retinopathy of prematurity \u2013 results from the gutenberg prematurity study young (GPSY)","volume":"103","author":"Fie\u00df","year":"2025","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.oret.2022.02.006","article-title":"Time course of retinopathy of prematurity regression and reactivation after treatment with ranibizumab or laser in the RAINBOW trial","volume":"6","author":"Fleck","year":"2022","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib42","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0161-6420(85)33919-2","article-title":"An international classification of retinopathy of prematurity: clinical experience","volume":"92","author":"Flynn","year":"1985","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.15252\/emmm.201707966","article-title":"Photoreceptor glucose metabolism determines normal retinal vascular growth","volume":"10","author":"Fu","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.preteyeres.2026.101531_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-023-09872-x","article-title":"FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROP","volume":"26","author":"Fu","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.preteyeres.2026.101531_bib45","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.oret.2025.05.008","article-title":"Risk factors for reoperation in vitrectomy for stage 4A retinopathy of prematurity","volume":"9","author":"Fukushima","year":"2025","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib46","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4103\/ijo.IJO_3016_20","article-title":"Outcomes of early versus deferred laser after intravitreal ranibizumab in aggressive posterior retinopathy of prematurity","volume":"69","author":"Gangwe","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1165356","article-title":"Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity","volume":"14","author":"Gao","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.preteyeres.2026.101531_bib49","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.preteyeres.2026.101531_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.23933","article-title":"Neonatal sepsis episodes and retinopathy of prematurity in very preterm infants","volume":"7","author":"Glaser","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.preteyeres.2026.101531_bib51","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1097\/01.iae.0000244288.63757.be","article-title":"25-Gauge pars plicata vitrectomy for stage 4 and 5 retinopathy of prematurity","volume":"26","author":"Gonzales","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archophthalmol.2010.72","article-title":"Final visual acuity results in the early treatment for retinopathy of prematurity study","volume":"128","author":"Good","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ophtha.2025.09.020","article-title":"Treating retinopathy of prematurity with dexamethasone eye drops: a difference-in-differences study in Sweden using register data","volume":"133","author":"Gr\u00e4nse","year":"2026","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib54","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1001\/archopht.121.12.1697","article-title":"Risk analysis of prethreshold retinopathy of prematurity","volume":"121","author":"Hardy","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ajo.2020.05.025","article-title":"Retinopathy of prematurity: evolving treatment with anti-vascular endothelial growth factor","volume":"218","author":"Hartnett","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/EB.S105319","article-title":"Advances in diagnosis, clinical care, research, and treatment in retinopathy of prematurity","volume":"8","author":"Hartnett","year":"2016","journal-title":"Eye Brain"},{"key":"10.1016\/j.preteyeres.2026.101531_bib57","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s40123-023-00744-7","article-title":"Laser versus Anti-VEGF: a paradigm shift for treatment-warranted retinopathy of prematurity","volume":"12","author":"Hartnett","year":"2023","journal-title":"Ophthalmol. Ther."},{"issue":"9902","key":"10.1016\/j.preteyeres.2026.101531_bib58","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2026.101531_bib59","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/j.1755-3768.2012.02469.x","article-title":"Serum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurity","volume":"91","author":"Hoerster","year":"2013","journal-title":"Acta Ophthalmol."},{"issue":"18","key":"10.1016\/j.preteyeres.2026.101531_bib60","doi-asserted-by":"crossref","first-page":"E2516","DOI":"10.1073\/pnas.1523005113","article-title":"Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity","volume":"113","author":"Hoppe","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2026.101531_bib61","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.oret.2022.07.005","article-title":"Late vitreoretinal complications of regressed retinopathy of prematurity: retinal break, vitreous hemorrhage, and retinal detachment","volume":"7","author":"Hsu","year":"2023","journal-title":"Ophthalmol. Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib62","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.ophtha.2017.03.018","article-title":"Ranibizumab injection as primary treatment in patients with retinopathy of prematurity: anatomic outcomes and influencing factors","volume":"124","author":"Huang","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40001-024-02206-7","article-title":"Effect and factors associated with reactivation after intravitreal conbercept or aflibercept in retinopathy of prematurity","volume":"30","author":"Huang","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.preteyeres.2026.101531_bib64","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ophtha.2015.11.003","article-title":"Clinical models and algorithms for the prediction of retinopathy of prematurity: a report by the American academy of ophthalmology","volume":"123","author":"Hutchinson","year":"2016","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","article-title":"The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease","volume":"96","author":"Iadecola","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.preteyeres.2026.101531_bib66","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/IAE.0000000000003196","article-title":"Factors associated with reactivation after intravitreal bevacizumab or ranibizumab therapy in infants with retinopathy of prematurity","volume":"41","author":"Iwahashi","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib67","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3390\/ijms24032416","article-title":"Long-term visual prognosis of patients following lens-sparing vitrectomy for stage 4A retinopathy of prematurity","volume":"24","author":"Iwahashi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2026.101531_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115535","article-title":"Research progress of VEGFR small molecule inhibitors in ocular neovascular diseases","volume":"257","author":"Jiang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.preteyeres.2026.101531_bib69","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/bjophthalmol-2016-309198","article-title":"Long-term functional results following vitrectomy for advanced retinopathy of prematurity","volume":"101","author":"Karacorlu","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib70","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/IAE.0000000000001562","article-title":"Therapeutic outcomes after ENDORESECTION of complex retinal capillary hemangioblastoma","volume":"38","author":"Karacorlu","year":"2018","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaapos.2017.10.006","article-title":"Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity","volume":"22","author":"Kennedy","year":"2018","journal-title":"J. AAPOS"},{"key":"10.1016\/j.preteyeres.2026.101531_bib72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exer.2018.01.020","article-title":"The effect of a single anti-Vascular Endothelial Growth Factor injection on neonatal growth and organ development: In-vivo study","volume":"169","author":"Khalili","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101531_bib73","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.ophtha.2022.06.008","article-title":"Retinopathy of prematurity treatment trends from 2003 to 2020 in the United States","volume":"129","author":"Khan","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib74","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/IAE.0b013e318296e26d","article-title":"Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity","volume":"34","author":"Kim","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042384","article-title":"Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis","volume":"11","author":"Kong","year":"2021","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.preteyeres.2026.101531_bib76","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00347-018-0700-6","article-title":"[Long-term effects of anti-VEGF therapy for retinopathy of prematurity]","volume":"115","author":"Krohne","year":"2018","journal-title":"Ophthalmologe"},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/IAE.0000000000003627","article-title":"Rate of and time to complete retinal vascularization in premature infants and associated factors","volume":"43","author":"Lai","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib78","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ophtha.2005.03.031","article-title":"Anatomic success rate after 3-port lens-sparing vitrectomy in stage 4A or 4B retinopathy of prematurity","volume":"112","author":"Lakhanpal","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40272-020-00433-z","article-title":"Ranibizumab: a review in retinopathy of prematurity","volume":"23","author":"Lee","year":"2021","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.preteyeres.2026.101531_bib80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajo.2018.05.002","article-title":"Macular structures, optical components, and visual acuity in preschool children after intravitreal bevacizumab or laser treatment","volume":"192","author":"Lee","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib81","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ophtha.2014.05.015","article-title":"Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity","volume":"121","author":"Lepore","year":"2014","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s42003-023-05743-9","article-title":"Genome-wide association identifies novel ROP risk loci in a multiethnic cohort","volume":"7","author":"Li","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib83","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/archopht.124.12.1711","article-title":"Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity","volume":"124","author":"L\u00f6fqvist","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib84","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archophthalmol.2009.69","article-title":"Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I","volume":"127","author":"L\u00f6fqvist","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/IAE.0000000000001126","article-title":"Retinal vascular development with 0.312 MG intravitreal bevacizumab to treat severe posterior retinopathy of prematurity: a longitudinal fluorescein angiographic study","volume":"37","author":"Lorenz","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib86","first-page":"2311","article-title":"Profile of conbercept in the treatment of neovascular age-related macular degeneration","volume":"9","author":"Lu","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.preteyeres.2026.101531_bib87","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preteyeres.2017.10.001","article-title":"Development of the hyaloid, choroidal and retinal vasculatures in the fetal human eye","volume":"62","author":"Lutty","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2026.101531_bib88","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1167\/iovs.16-20680","article-title":"Recurrence of retinopathy of prematurity after intravitreal ranibizumab monotherapy: timing and risk factors","volume":"58","author":"Lyu","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101531_bib89","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/IAE.0000000000002834","article-title":"Viscodelamination of localized retrolental plaques during lens-sparing vitrectomy in eyes with pediatric tractional vitreoretinopathy","volume":"43","author":"Lyu","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib90","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/IAE.0000000000002748","article-title":"Use of an iris speculum for retrolental membrane dissection for stage 5 prematurity of retinopathy complicated with pupillary adhesion","volume":"43","author":"Lyu","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.aopr.2026.05.001","article-title":"Preliminary efficacy of intravitreal faricimab for type 1 retinopathy of prematurity: a pilot case series","author":"Ma","year":"2026","journal-title":"Adv. Ophthalmol. Pract. Res."},{"key":"10.1016\/j.preteyeres.2026.101531_bib92","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/IAE.0000000000003541","article-title":"Structural outcome after surgery for stage 5 retinopathy of prematurity based on the new international classification: icrop 3","volume":"42","author":"Mano","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102567","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomized trial","volume":"71","author":"Marlow","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.preteyeres.2026.101531_bib94","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ajo.2009.05.031","article-title":"A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity","volume":"148","author":"Micieli","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib95","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.preteyeres.2026.101531_bib96","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41401-025-01642-3","article-title":"HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis","volume":"47","author":"Mitchell","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.preteyeres.2026.101531_bib97","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2026.101531_bib98","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3174\/ajnr.A1987","article-title":"Bevacizumab (Avastin)","volume":"31","author":"Mukherji","year":"2010","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib99","doi-asserted-by":"crossref","DOI":"10.1111\/ped.70366","article-title":"Urinary biomarkers and serum VEGF in preterm infants with retinopathy of prematurity treated with ranibizumab","volume":"68","author":"Nagaoka","year":"2026","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.preteyeres.2026.101531_bib100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nrd2157","article-title":"Ranibizumab","volume":"5","author":"Narayanan","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.preteyeres.2026.101531_bib101","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10103-020-03130-y","article-title":"Role of LASERS in stage 4A retinopathy of prematurity (ROP)","volume":"36","author":"Narnaware","year":"2021","journal-title":"Laser Med. Sci."},{"key":"10.1016\/j.preteyeres.2026.101531_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.806691","article-title":"Health equity and disparities in ROP care: a need for systematic evaluation","volume":"10","author":"Ndukwe","year":"2022","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.preteyeres.2026.101531_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-15271-7","article-title":"The ocular shape and retinal structure in children with a history of treated retinopathy of prematurity","volume":"15","author":"Nishi","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.preteyeres.2026.101531_bib105","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jamaophthalmol.2022.3788","article-title":"Pulmonary hypertension in preterm infants treated with laser vs anti-vascular endothelial growth factor therapy for retinopathy of prematurity","volume":"140","author":"Nitkin","year":"2022","journal-title":"JAMA Ophthalmol."},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.70094","article-title":"Disproportionality analysis of intravitreal ranibizumab, aflibercept, and brolucizumab for cardiovascular and cerebrovascular events","volume":"66","author":"Nosaka","year":"2026","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib107","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ophtha.2014.11.004","article-title":"Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity","volume":"122","author":"Nudleman","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib108","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ophtha.2017.11.009","article-title":"Glaucoma after lens-sparing vitrectomy for advanced retinopathy of prematurity","volume":"125","author":"Nudleman","year":"2018","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.preteyeres.2026.101531_bib109","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/glia.23189","article-title":"Astrocytes follow ganglion cell axons to establish an angiogenic template during retinal development","volume":"65","author":"O'Sullivan","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.preteyeres.2026.101531_bib110","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s00417-023-06227-6","article-title":"Visual field after anti-vascular endothelial growth factor therapy and laser treatment for retinopathy of prematurity","volume":"261","author":"Obata","year":"2023","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib111","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/bjophthalmol-2018-312922","article-title":"Parameters affecting postoperative success of surgery for stage 4A\/4B ROP","volume":"103","author":"\u00d6zsaygili","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib112","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archopht.123.3.311","article-title":"15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity","volume":"123","author":"Palmer","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib113","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10792-021-02095-3","article-title":"Scleral buckling surgery for stage 4A and 4B retinopathy of prematurity in critically ill neonates","volume":"42","author":"Papageorgiou","year":"2022","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib114","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41433-021-01679-8","article-title":"Evolving outcomes of surgery for retinal detachment in retinopathy of prematurity: the need for a national service in the United Kingdom : an audit of surgery for acute tractional retinal detachment complicating ROP in the UK","volume":"36","author":"Patel","year":"2022","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.preteyeres.2026.101531_bib115","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/0002-9394(52)91140-9","article-title":"Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations","volume":"35","author":"Patz","year":"1952","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib116","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00417-020-04600-3","article-title":"Subretinal injection of ranibizumab in advanced pediatric vasoproliferative disorders with total retinal detachments","volume":"258","author":"Peng","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.961152","article-title":"Two-step widefield fundus fluorescein angiography-assisted laser photocoagulation in pediatric retinal vasculopathy: a pilot study","volume":"9","author":"Peng","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2026.101531_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.850129","article-title":"Dry-lensectomy assisted lensectomy in the management for end-stage familial exudative vitreoretinopathy complicated with anterior segment abnormalities","volume":"9","author":"Peng","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2026.101531_bib119","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/bjophthalmol-2021-320738","article-title":"Validation of DIGIROP models and decision support tool for prediction of treatment for retinopathy of prematurity on a contemporary swedish cohort","volume":"107","author":"Pivodic","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib120","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.ophtha.2004.06.021","article-title":"Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity","volume":"111","author":"Prenner","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib121","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0161-6420(96)30487-9","article-title":"Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity from the cryotherapy for retinopathy of prematurity trial. The CRYO-Retinopathy of Prematurity Cooperative Group","volume":"103","author":"Quinn","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib122","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2014.1604","article-title":"Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity","volume":"132","author":"Quinn","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib123","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00417-020-05063-2","article-title":"Clinico-demographic profile and outcomes of 25-gauge vitrectomy in advanced stage 5 retinopathy of prematurity","volume":"259","author":"Rajan","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"9","key":"10.1016\/j.preteyeres.2026.101531_bib124","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI126655","article-title":"Roles of HIFs and VEGF in angiogenesis in the retina and brain","volume":"129","author":"Rattner","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.preteyeres.2026.101531_bib125","first-page":"185","article-title":"Surgical management in advanced stages of retinopathy of prematurity; our experience","volume":"4","author":"Roohipoor","year":"2009","journal-title":"J. Ophthalmic Vis. Res."},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib126","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12964-025-02083-5","article-title":"Microglial depletion decreases M\u00fcller cell maturation and inner retinal vascular density","volume":"23","author":"Rowthorn-Apel","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.preteyeres.2026.101531_bib127","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41433-024-03563-7","article-title":"Primary scleral buckling vs. vitrectomy for stage 4A retinopathy of prematurity: a systematic review and meta-analysis of surgical outcomes","volume":"39","author":"Saeed","year":"2025","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib128","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preteyeres.2026.101531_bib129","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/jp.2015.112","article-title":"Multicenter observational study comparing sedation\/analgesia protocols for laser photocoagulation treatment of retinopathy of prematurity","volume":"35","author":"Sato","year":"2015","journal-title":"J. Perinatol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib130","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41433-019-0643-4","article-title":"Retinopathy of prematurity treatment: asian perspectives","volume":"34","author":"Sen","year":"2020","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.preteyeres.2026.101531_bib131","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1186\/s12967-024-05441-y","article-title":"Insights to Ang\/Tie signaling pathway: another rosy dawn for treating retinal and choroidal vascular diseases","volume":"22","author":"Sha","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.preteyeres.2026.101531_bib132","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/ICB.0000000000000221","article-title":"Concurrent scleral buckle and intravitreal bevacizumab for advanced retinopathy of prematurity-related retinal detachment","volume":"10","author":"Shah","year":"2016","journal-title":"Retin. Cases Brief Rep."},{"key":"10.1016\/j.preteyeres.2026.101531_bib133","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5409\/wjcp.v7.i1.62","article-title":"Outcomes of transconjuctival sutureless 27-gauge vitrectomy for stage 4 retinopathy of prematurity","volume":"7","author":"Shah","year":"2018","journal-title":"World J. Clin. Pediatr."},{"key":"10.1016\/j.preteyeres.2026.101531_bib134","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40265-022-01713-3","article-title":"Faricimab: first approval","volume":"82","author":"Shirley","year":"2022","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.preteyeres.2026.101531_bib135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10456-018-9618-5","article-title":"Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy","volume":"21","author":"Simmons","year":"2018","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib136","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2026.101531_bib137","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jamapediatrics.2017.4838","article-title":"Comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity: a randomized clinical trial","volume":"172","author":"Stahl","year":"2018","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.preteyeres.2026.101531_bib138","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomized controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.preteyeres.2026.101531_bib139","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1111\/aos.14852","article-title":"Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study","volume":"100","author":"Stahl","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jama.2022.10564","article-title":"Effect of intravitreal aflibercept vs laser photocoagulation on treatment success of retinopathy of prematurity","volume":"328","author":"Stahl","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.preteyeres.2026.101531_bib141","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jama.2022.10564","article-title":"Effect of intravitreal aflibercept vs laser photocoagulation on treatment success of retinopathy of prematurity: the FIREFLEYE randomized clinical trial","volume":"328","author":"Stahl","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.preteyeres.2026.101531_bib142","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.8383","article-title":"Intravitreal aflibercept vs laser therapy for retinopathy of prematurity: two-year efficacy and safety outcomes in the nonrandomized controlled trial FIREFLEYE next","volume":"7","author":"Stahl","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.preteyeres.2026.101531_bib143","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2025-002303","article-title":"Different ranibizumab dosages for retinopathy of prematurity: 5-year follow-up data of the randomized, controlled CARE-ROP study","volume":"10","author":"Stahl","year":"2025","journal-title":"BMJ Open Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib144","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000549717","article-title":"Three-year outcomes of intravitreal aflibercept versus laser therapy for retinopathy of prematurity: interim analysis of the efficacy and safety outcomes in the FIREFLEYE next trial","volume":"123","author":"Stahl","year":"2026","journal-title":"Neonatology"},{"issue":"3","key":"10.1016\/j.preteyeres.2026.101531_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279634","article-title":"Inhibition of VEGF receptors induces pituitary apoplexy: an experimental study in mice","volume":"18","author":"Sugita","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2026.101531_bib146","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00417-016-3443-6","article-title":"Treatment for stage 4A retinopathy of prematurity: laser and\/or ranibizumab","volume":"255","author":"Sukgen","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib147","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00417-018-4168-5","article-title":"Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity","volume":"257","author":"Sukgen","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib148","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/jcm15051912","article-title":"Use of aflibercept to treat retinopathy of prematurity in children with extremely low birth weight","volume":"15","author":"Szwajkowska","year":"2026","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2026.101531_bib149","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00417-025-06801-0","article-title":"Long-term visual function and refractive changes after vitrectomy for stage 4 retinopathy of prematurity","volume":"263","author":"Tachibana","year":"2025","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/bjophthalmol-2013-304109","article-title":"Fluorescein angiographic observations of peripheral retinal vessel growth in infants after intravitreal injection of bevacizumab as sole therapy for zone I and posterior zone II retinopathy of prematurity","volume":"98","author":"Tahija","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib151","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/sjopt.sjopt_220_21","article-title":"Retinopathy of prematurity screening: a narrative review of current programs, teleophthalmology, and diagnostic support systems","volume":"36","author":"Tan","year":"2022","journal-title":"Saudi J. Ophthalmol.: Off. J. Saudi Ophthalmol. Soc."},{"issue":"23","key":"10.1016\/j.preteyeres.2026.101531_bib152","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/CIRCULATIONAHA.117.033062","article-title":"Decreased expression of vascular endothelial growth factor receptor 1 contributes to the pathogenesis of hereditary hemorrhagic telangiectasia type 2","volume":"138","author":"Thalgott","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.preteyeres.2026.101531_bib153","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40942-023-00502-8","article-title":"Teleophthalmology and retina: a review of current tools, pathways and services","volume":"9","author":"Than","year":"2023","journal-title":"Int. J. Retina Vitr"},{"key":"10.1016\/j.preteyeres.2026.101531_bib154","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.2147\/OPTH.S562553","article-title":"Real-world visual and anatomical outcomes of laser therapy versus intravitreal anti-vascular endothelial growth factor injection for retinopathy of prematurity: a 10-Year retrospective cohort study at a tertiary center in Thailand","volume":"19","author":"Thanomteeranant","year":"2025","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archopht.1984.01040030908011","article-title":"An international classification of retinopathy of prematurity","volume":"102","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib156","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib157","first-page":"56","article-title":"Management of retinopathy of Prematurity--Use of Anti-VEGF therapy","volume":"7","author":"Tran","year":"2018","journal-title":"Asia Pac. J. Ophthalmol. (Phila)"},{"issue":"5","key":"10.1016\/j.preteyeres.2026.101531_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2026.101125","article-title":"Lipidomics reveals circulating lipid biomarkers for retinopathy of prematurity in preterm infants","volume":"6","author":"Tro\u0161t","year":"2026","journal-title":"Ophthalmol. Sci."},{"issue":"4","key":"10.1016\/j.preteyeres.2026.101531_bib159","article-title":"Insulin-like growth factor-1 for the prevention or treatment of retinopathy of prematurity","volume":"4","author":"Trzaski","year":"2026","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preteyeres.2026.101531_bib160","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ophtha.2020.11.012","article-title":"Neurodevelopmental outcomes after bevacizumab treatment for retinopathy of prematurity: a meta-analysis","volume":"128","author":"Tsai","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib161","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bjo.2003.022962","article-title":"Late onset vitreoretinal complications of regressed retinopathy of prematurity","volume":"88","author":"Tufail","year":"2004","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.preteyeres.2026.101531_bib162","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1814","article-title":"Hypertension and neuroimaging changes after bevacizumab for retinopathy of prematurity","volume":"145","author":"Twitty","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.preteyeres.2026.101531_bib163","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.oret.2020.02.001","article-title":"Reactivation of retinopathy of prematurity in adults and adolescents","volume":"4","author":"Uner","year":"2020","journal-title":"Ophthalmol. Retina"},{"issue":"5","key":"10.1016\/j.preteyeres.2026.101531_bib164","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American academy of ophthalmology","volume":"124","author":"VanderVeen","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib165","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s003470050497","article-title":"[threshold value retinopathy of prematurity. Visual outcome of 2-year-old children after cryocoagulation]","volume":"96","author":"Vanselow","year":"1999","journal-title":"Ophthalmol. Times: Z. Dtsch. Ophthalmol. Ges."},{"key":"10.1016\/j.preteyeres.2026.101531_bib166","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0301-4738.126178","article-title":"The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting","volume":"62","author":"Vinekar","year":"2014","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib167","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcjo.2014.11.005","article-title":"SUNDROP: six years of screening for retinopathy of prematurity with telemedicine","volume":"50","author":"Wang","year":"2015","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib168","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ebiom.2018.08.033","article-title":"Automated retinopathy of prematurity screening using deep neural networks","volume":"35","author":"Wang","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.preteyeres.2026.101531_bib169","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3390\/jcm14030810","article-title":"A review of refractive errors post anti-vascular endothelial growth factor injection and laser photocoagulation treatment for retinopathy of prematurity","volume":"14","author":"Wang","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.preteyeres.2026.101531_bib170","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ophtha.2010.04.018","article-title":"Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in Taiwan","volume":"118","author":"Wu","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib171","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajo.2012.06.010","article-title":"An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan","volume":"155","author":"Wu","year":"2013","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib172","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/IAE.0000000000001209","article-title":"Serum vascular endothelial growth factor after bevacizumab or ranibizumab treatment for retinopathy of prematurity","volume":"37","author":"Wu","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.preteyeres.2026.101531_bib173","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1007\/s00417-022-05628-3","article-title":"Repeated intravitreal ranibizumab for reactivated retinopathy of prematurity after intravitreal ranibizumab monotherapy: vascular development analysis","volume":"260","author":"Xia","year":"2022","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib174","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1111\/aos.12055","article-title":"Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection","volume":"91","author":"Xu","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib175","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5029278","article-title":"Combination of intravitreal injection of ranibizumab and photocoagulation for the treatment of aggressive posterior retinopathy of prematurity with vitreous hemorrhage","author":"Xu","year":"2016","journal-title":"J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.preteyeres.2026.101531_bib176","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12473","article-title":"Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1\u03b1-VEGF pathway in oxygen-induced retinopathy mice","volume":"64","author":"Xu","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.preteyeres.2026.101531_bib177","article-title":"Immediate sequential bilateral pediatric vitreoretinal surgery: an international multicenter study","volume":"123","author":"Y","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2026.101531_bib178","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10456-024-09948-2","article-title":"Timed topical dexamethasone eye drops improve mitochondrial function to prevent severe retinopathy of prematurity","volume":"27","author":"Yagi","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.preteyeres.2026.101531_bib179","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10456-024-09948-2","article-title":"Timed topical dexamethasone eye drops improve mitochondrial function to prevent severe retinopathy of prematurity","volume":"27","author":"Yagi","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.preteyeres.2026.101531_bib180","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40266-014-0176-2","article-title":"Intravitreal aflibercept (Eylea(\u00ae)): a review of its use in patients with macular oedema secondary to central retinal vein occlusion","volume":"31","author":"Yang","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.preteyeres.2026.101531_bib181","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaapos.2023.05.008","article-title":"Reactivation of retinopathy of prematurity six years after intravitreal injection of bevacizumab","volume":"27","author":"Yasin","year":"2023","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.preteyeres.2026.101531_bib182","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamaophthalmol.2019.4608","article-title":"A prediction model for retinopathy of prematurity\u2014is it ready for prime time?","volume":"138","author":"Ying","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib183","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/jamaophthalmol.2023.6198","article-title":"Intra-Anterior chamber injection of ranibizumab in advanced pediatric vitreoretinal diseases","volume":"142","author":"Zhang","year":"2024","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib184","article-title":"Vascular development analysis: a study for tertiary anti-vascular endothelial growth factor therapy after second reactivation of retinopathy of prematurity","volume":"11","author":"Zhang","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.preteyeres.2026.101531_bib185","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/ceo.14575","article-title":"Comparison of clinical and angiographic outcomes of ranibizumab and aflibercept in type 1 and aggressive retinopathy of prematurity","volume":"53","author":"Zhang","year":"2025","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2026.101531_bib186","first-page":"37","article-title":"Retinopathy of prematurity screening and treatment cost in Brazil","volume":"36","author":"Zin","year":"2014","journal-title":"Rev. Panam. Salud Publica = Pan Am. J. Public Health"}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946226000972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946226000972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:37:15Z","timestamp":1792445835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946226000972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":186,"alternative-id":["S1350946226000972"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2026.101531","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinopathy of prematurity in the anti-VEGF era: Screening systems and practical treatment decision-making across anti-VEGF, laser, and surgery","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2026.101531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101531"}}